Biomarkers Predicting Recurrence and Progression of Ductal Carcinoma In Situ Treated by Lumpectomy Alone

被引：8
|
作者：
Allred, D. Craig [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2010年 / 102卷 / 09期
关键词：
SURGICAL ADJUVANT BREAST; INTRADUCTAL-CARCINOMA; PATHOLOGICAL FINDINGS; PROTOCOL B-17; CANCER; TAMOXIFEN; EXPRESSION; PHENOTYPE; DCIS; B-24;
D O I：
10.1093/jnci/djq118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 587
页数：3
相关论文
共 50 条
  • [31] Outcomes of Screening-Detected Ductal Carcinoma In Situ Treated with Wide Excision Alone
    Jonathan Fong
    Emil D. Kurniawan
    Allison K. Rose
    Arlene Mou
    John P. Collins
    Julie A. Miller
    G. Bruce Mann
    Annals of Surgical Oncology, 2011, 18 : 3778 - 3784
  • [32] Multiplexed Analysis of Myoepithelial and Immune Cell Biomarkers to Predict Progression of Ductal Carcinoma in Situ
    Jindal, S.
    Mitchell, E.
    Chan, T. S.
    Schedin, P.
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (10): : 2353 - 2353
  • [33] Identifying Morphological Biomarkers for Progression of Ductal Carcinoma in Situ of the Breast Through Computational Analysis
    Sidlauskas, Kastytis
    Shephard, Adam
    Thorat, Mangesh
    Rajpoot, Nasir
    Jones, J. Louise
    JOURNAL OF PATHOLOGY, 2024, 264 : S16 - S16
  • [34] Prognostic significance of necrosis in evaluating risk for recurrence of ductal carcinoma in situ of the breast and progression to invasive carcinoma: Survey of 166 conservatively treated patients
    Goonewardene, S
    Palazzo, J
    Cornfield, D
    Schwartz, G
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 531 - 532
  • [35] Recurrence In Ductal Carcinoma In Situ And Molecular Subtypes
    Makris, Georgios Marios
    Poulakaki, Nikiforita
    Battista, Marco Johannes
    Boehm, Daniel
    Petraki, Kalliopi
    Bafaloukos, Dimitrios
    Sergentanis, Theodoros
    Siristatidis, Charalampos
    Chrelias, Charalampos
    Papantoniou, Nikolaos
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 49 - 50
  • [36] Recurrence after Mastectomy for Ductal Carcinoma In Situ
    Godat, Laura N.
    Horton, Janet K.
    Shen, Perry
    Stewart, John H.
    Wentworth, Stacy
    Levine, Edward A.
    AMERICAN SURGEON, 2009, 75 (07) : 592 - 595
  • [37] Ductal carcinoma in situ: Factors affecting recurrence
    Hiew, LY
    Stallard, S
    Purushotham, AD
    Mehana, H
    Cordiner, C
    Dobson, H
    Mallon, EA
    George, WD
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S8 - S8
  • [38] Recurrence of Extensive Ductal Carcinoma in Situ Treated with Breast Conserving Surgery Compared to Mastectomy
    Que, J.
    Kim, D.
    Chen, L.
    Liu, R. Q.
    Zhang, M.
    Dingee, C. K.
    Warburton, R.
    McKevitt, E.
    Kuusk, U.
    Pao, J.
    Bazzarelli, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S71 - S71
  • [39] Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
    Gorringe, Kylie L.
    Fox, Stephen B.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [40] A predictive model for local recurrence in patients treated for ductal carcinoma in situ of the breast (DCIS)
    Martinez-Perez, C.
    Turnbull, A. K.
    Fernando, A.
    Ekatah, G. E.
    Arthur, L. M.
    Cartlidge, C. W.
    Johns, N.
    Sims, A. H.
    Thomas, J. S.
    Dixon, J. M.
    CANCER RESEARCH, 2019, 79 (04)
12345